This company has been marked as potentially delisted and may not be actively trading. ZS Pharma (ZSPH) News Today Add Share Share Headlines Stock AnalysisBuy This Stock ZSPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Zscaler's Valuation Woes: A Case For SellingOctober 21, 2024 | seekingalpha.comZscaler, Inc. (ZS) Goldman Sachs Communacopia + Technology Conference 2024 (Transcript)September 11, 2024 | seekingalpha.comZscaler, Inc. (ZS) Q4 2024 Earnings Call TranscriptSeptember 4, 2024 | seekingalpha.comZscaler Is Still Unprofitable, But Is Growing FastAugust 6, 2024 | seekingalpha.comDaniel Janney's Net WorthMay 17, 2024 | benzinga.comZscaler: This Is A Dip Well Worth BuyingMarch 12, 2024 | seekingalpha.comZscaler, Inc. (ZS)March 4, 2024 | ca.finance.yahoo.comZscaler Stock (NASDAQ:ZS), Quotes and News SummaryFebruary 24, 2024 | benzinga.comZscaler, Inc. Common Stock (ZS)February 13, 2024 | nasdaq.comAstraZeneca Gets 'Complete Response Letter' From FDA on Hyperkalaemia TreatmentSeptember 2, 2023 | thestreet.comZscaler Inc.June 11, 2023 | wsj.comZscaler Inc ZS Stock QuoteMay 21, 2023 | morningstar.comMGuru Fundamental Report for ZSApril 6, 2023 | nasdaq.comKintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World's First Topical Use PROTAC CompoundMarch 9, 2023 | finance.yahoo.comZS Pharma (ZSPH) Stock Climbing on Preliminary Acquisition TalksJanuary 9, 2023 | thestreet.comZscaler (NASDAQ: ZS)September 24, 2022 | fool.comZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-OffMay 1, 2022 | thestreet.comZs Pharma I (ZSPH)January 5, 2022 | investing.com Get ZS Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSPH and its competitors with MarketBeat's FREE daily newsletter. Email Address ZSPH Media Mentions By Week ZSPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZSPH News Sentiment▼0.000.63▲Average News Sentiment ZSPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZSPH Articles This Week▼00▲ZSPH Articles Average Week Get ZS Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZSPH) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZS Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZS Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access